General Archive
-
News releases
Aptuscan acquired by Avacta
Aptuscan, a spin out company based on research carried out by Paul Ko Ferrigno whilst working at the MRC Cancer…
-
News releases
MRC Technology to manage intellectual property for AICR
This is the first such agreement signed by MRC Technology, delivering on a new strategy to broaden its service to…
-
News releases
MRC scientists redefine how our immune system responds to viruses
Landmark research from the Medical Research Council (MRC) has discovered that antibodies can fight viruses from within infected cells. This…
-
News releases
Scientists ‘give botox a facelift’ to improve use for Parkinson’s
Researchers funded by the Medical Research Council (MRC) have developed a new method of joining and rebuilding molecules in the…
-
News releases
1st patient treated with BAN2401
BAN2401, the antibody by MRC Technology humanized for Swedish biopharmaceutical company BioArctic Neuroscience AB (Stockholm), has entered clinical trials to…
-
News releases
MRC People Exchange Programme
The MRC People Exchange Programme aims to stimulate collaborative research across industry and academia, develop skills and transfer knowledge. It…
-
News releases
MRC Technology enters into an exclusive license agreement with Genentech
Genentech, Inc.has entered into an exclusive licence to a series of small molecule drug candidates for the potential treatment of…
-
News releases
“Skills Swap” to exploit expertise for patient benefit
Cancer Research Technology (CRT) and MRCT will ‘swap’ medical discoveries to accelerate the translation of early scientific research into patient…
-
News releases
AstraZeneca and MRC Technology form strategic alliance in discovery research, utilising shared compound libraries
The companies will combine up to 100,000 compounds from AstraZeneca’s collection with the MRC Technology compound library of approximately 50,000…
-
News releases
O2h provides multi-FTE -synthetic chemistry services to MRCT
MRCT translates cutting edge scientific discoveries into commercial products, two of which (Tysabri and Actemra) are already on the market.…
-
News releases
MRCT’s call for targets
A major centre created by the Medical Research Council (MRC) and MRC Technology (MRCT) in order to fast-track the discovery…
-
News releases
Collaboration between Georg-August-University Göttingen, Universitätsmedizin, the University of Regensburg and MRCT
The collaboration will focus on development of a novel therapy of inflammatory and immune diseases based on the depletion of…